Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110790755A reveals a novel high-yield route for Canagliflozin Peroxide, offering significant cost reduction and supply reliability for SGLT2 inhibitor manufacturers.
Patent CN114292176B reveals iron-catalyzed synthesis for high-purity diphenyldiquinone. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN110606805A reveals a dual-synthesis route offering high purity and environmental compliance for global supply chains. This method ensures reliable availability of critical fine chemical intermediates for pharmaceutical applications.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN105693627A reveals efficient Ru-pheox catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN104193674B details a low-temperature phase-transfer catalytic route for flunixin meglumine, offering enhanced purity and streamlined manufacturing for veterinary pharmaceutical supply chains.
Patent CN108191778A reveals one pot synthesis reducing costs. Enhances supply chain reliability for high purity pharmaceutical intermediates manufacturing globally.
Patent CN112795606A reveals a novel PNP/NRK enzymatic route for NMN. Achieve superior conversion rates and cost efficiency in pharmaceutical intermediate manufacturing.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Patent CN108047118B reveals a metal-free synthesis of 3-indoleselenyl alcohols using elemental selenium, offering high purity and scalable production for pharma intermediates.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Discover the metal-free synthesis of ortho-silyl-substituted tert-butyl peroxide via patent CN118307580A. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing.
Patent CN101555218A reveals a novel NaOH/PEG-1000 method. Offers high yield and cost reduction for electronic chemical manufacturing and pharma intermediates.
Novel Penicillium-derived monoamine oxidase enables high-concentration biocatalysis for antiviral drug intermediates, ensuring supply chain stability and cost efficiency.
Patent CN119082064B reveals mutant carbonyl reductase for Pro-Xylane. High yield, low cost, scalable biocatalysis for cosmetic manufacturers.
Novel triflate catalyst method for Clindamycin 3,4-isopropylidene. High yield, low waste, reliable pharmaceutical intermediates supplier for global supply chains.
Novel green synthesis of trans-alpha-benzoin oxime using imidazolium ionic liquids. High-purity mining chemical intermediate with reduced toxicity and scalable production capabilities.
Novel visible-light induced method for quinoxalines using non-activated amines. Cost-effective, green synthesis for reliable pharmaceutical intermediate supply chain.
Patent CN118851967A details a green visible light method for trifluoromethylselenosylstyrene derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Pd-Pt-Zn catalyst enables 98% CHDA selectivity. Reduces decarboxylation. Ideal for reliable fine chemical intermediate supplier partnerships.